Search research articles
Contact Us
Filters
Showing results (31-40 of 58) with videos related to
Page
of 6
Sort By:
AIDS (London, England)
|
December 23, 2008
Epidemiologically linked transmission of HIV-1 illustrates the impact of host genetics on virological outcome
Hendrik Streeck, Heiko Jessen, Claudia Kuecherer, et al.
Infection
|
May 13, 2020
High effectiveness of recommended first-line antiretroviral therapies in Germany: a nationwide, prospective cohort study
Markus Bickel, Christian Hoffmann, Eva Wolf, et al.
Infection
|
July 23, 2024
Is doxycycline post-exposure prophylaxis being utilised in Germany? Insights from an online survey among German men who have sex with men
Laura Wagner, Christoph Boesecke, Axel Baumgarten, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 29, 2019
Reinfection With the Hepatitis C Virus in Men Who Have Sex With Men After Successful Treatment With Direct-acting Antivirals in Germany: Current Incidence Rates, Compared With Rates During the Interferon Era
Patrick Ingiliz, Malte H Wehmeyer, Christoph Boesecke, et al.
Journal of Hepatology
|
September 22, 2016
HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe
Patrick Ingiliz, Thomas C Martin, Alison Rodger, et al.
Plos One
|
August 1, 2015
Benefit of Treatment Individualization in Patients with Chronic Hepatitis C Receiving Peginterferon Alfa-2a and Ribavirin in a Large Noninterventional Cohort Study
Wolf Peter Hofmann, Stefan Mauss, Thomas Lutz, et al.
Infectious Diseases and Therapy
|
April 15, 2025
Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) After A Viremic Event: A Pooled Analysis of Studies in People with HIV
Anton Pozniak, Chloe Orkin, Yazdan Yazdanpanah, et al.
Antiviral Therapy
|
December 18, 2013
Strategies for assignment of HIV-HCV genotype-1-coinfected patients to either dual-therapy or direct-acting antiviral agent-based triple-therapy
Mattias Mandorfer, Karin Neukam, Antonio Rivero, et al.
Scandinavian Journal of Infectious Diseases
|
July 24, 2013
HIV-associated lung cancer: survival in an unselected cohort
Christian Hoffmann, Fabienne Kohrs, Michael Sabranski, et al.
Journal of Clinical Gastroenterology
|
February 22, 2019
Has Increased Rollout of Direct Acting Antiviral Therapy Decreased the Burden of Late Presentation and Advanced Liver Disease in Patients Starting Hepatitis C Virus Therapy in Germany?
Jenny Bischoff, Christoph Boesecke, Patrick Ingiliz, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 58) with videos related to
Sort By:
Page
of 6
AIDS (London, England)
|
December 23, 2008
Epidemiologically linked transmission of HIV-1 illustrates the impact of host genetics on virological outcome
Hendrik Streeck, Heiko Jessen, Claudia Kuecherer, et al.
Infection
|
May 13, 2020
High effectiveness of recommended first-line antiretroviral therapies in Germany: a nationwide, prospective cohort study
Markus Bickel, Christian Hoffmann, Eva Wolf, et al.
Infection
|
July 23, 2024
Is doxycycline post-exposure prophylaxis being utilised in Germany? Insights from an online survey among German men who have sex with men
Laura Wagner, Christoph Boesecke, Axel Baumgarten, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 29, 2019
Reinfection With the Hepatitis C Virus in Men Who Have Sex With Men After Successful Treatment With Direct-acting Antivirals in Germany: Current Incidence Rates, Compared With Rates During the Interferon Era
Patrick Ingiliz, Malte H Wehmeyer, Christoph Boesecke, et al.
Journal of Hepatology
|
September 22, 2016
HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe
Patrick Ingiliz, Thomas C Martin, Alison Rodger, et al.
Plos One
|
August 1, 2015
Benefit of Treatment Individualization in Patients with Chronic Hepatitis C Receiving Peginterferon Alfa-2a and Ribavirin in a Large Noninterventional Cohort Study
Wolf Peter Hofmann, Stefan Mauss, Thomas Lutz, et al.
Infectious Diseases and Therapy
|
April 15, 2025
Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) After A Viremic Event: A Pooled Analysis of Studies in People with HIV
Anton Pozniak, Chloe Orkin, Yazdan Yazdanpanah, et al.
Antiviral Therapy
|
December 18, 2013
Strategies for assignment of HIV-HCV genotype-1-coinfected patients to either dual-therapy or direct-acting antiviral agent-based triple-therapy
Mattias Mandorfer, Karin Neukam, Antonio Rivero, et al.
Scandinavian Journal of Infectious Diseases
|
July 24, 2013
HIV-associated lung cancer: survival in an unselected cohort
Christian Hoffmann, Fabienne Kohrs, Michael Sabranski, et al.
Journal of Clinical Gastroenterology
|
February 22, 2019
Has Increased Rollout of Direct Acting Antiviral Therapy Decreased the Burden of Late Presentation and Advanced Liver Disease in Patients Starting Hepatitis C Virus Therapy in Germany?
Jenny Bischoff, Christoph Boesecke, Patrick Ingiliz, et al.
Page
of 6